CIK 0001736243 · <br>Emerging growth company
Acurx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ACXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 917-533-1469
- Business address
- 259 LIBERTY AVENUE, STATEN ISLAND, NY, 10305
- Former names
- Acurx Pharmaceuticals, LLC
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- CERT Other Certification
- 8-A12B Other Registration of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- FWP Offering Free Writing Prospectus
- S-1/A Offering Registration Statement
- S-1 Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
- UPLOAD Other SEC-generated Letter
Page 12 of 13 · 246 filings